Placental and pregnancy stem cells

0Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The placenta may prove to be a non-controversial source of hematopoietic and mesenchymal stem cells (MSCs) as well as endothelial progenitor cells. A "cocktail" of these three elements might be used in future to treat hypoxic ischemic encephalopathy (HIE) in the peripartum period for neuroregeneration, and a combination of these cells might also be used to treat one of the more than 80 diseases that have responded to stem cell transplantation (Table 1.1). Furthermore, these cells have the potential to treat degenerative diseases (e.g., heart disease), endocrine disorders (e.g., diabetes), and neurodegenerative diseases (e.g., stroke, Alzheimer's disease, Parkinson's disease, and spinal cord injuries). These cells may also be useful in the treatment of orthopedic problems. © Springer-Verlag London Limited 2009.

Cite

CITATION STYLE

APA

Mehta, A., Cetrulo, C., Stubblefield, P., & Cetrulo, K. (2009). Placental and pregnancy stem cells. In Frontiers of Cord Blood Science (pp. 3–18). Springer London. https://doi.org/10.1007/978-1-84800-167-1_1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free